EHA Takes Early Action on EU’s Forthcoming Biotech Act: Biotechnology Wonders 2026
The European Hematology Association (EHA) recently shared a post on X:
”The EU is developing new legislation that will impact hematology – the Biotech Act.
EHA ensures that hematologists are represented in this process.”
Read the preliminary recommendations for a Biotech Act here.
In 2024, the European Commission launched preparatory work on a landmark piece of legislation—the Biotech Act—set to be formally proposed in 2026.
Aimed at streamlining the development and market access of biotech products, the regulation also seeks to uphold high safety standards while bolstering the competitiveness and scale of the EU’s biotechnology sector.
Although the legislative text is still in the works, key stakeholders are already mobilizing.
The European Hematology Association (EHA) has actively stepped in to ensure the voice of hematologists is heard from the outset.
Through early advocacy and strategic engagement, EHA is positioning the hematology community to help shape a regulatory environment that supports innovation while protecting patient safety.
As the Biotech Act progresses, EHA remains committed to representing the field throughout every phase of the EU legislative process.
Latest updates in the World of Hematology featured in Hemostasis Today.
-
Jun 1, 2026, 11:16Ocima Richard Draza: Postpartum Hemorrhage – A Practical Step-by-Step Management Guide
-
Jun 1, 2026, 10:57Kyungjun Lim: How Will Future Mars Colonies Manage Their Supply Chains?
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership